A cross-sectional study of bone health in multiple sclerosis
- PMID: 19858462
- PMCID: PMC2769555
- DOI: 10.1212/WNL.0b013e3181beece8
A cross-sectional study of bone health in multiple sclerosis
Abstract
Background: Osteoporosis is an important risk factor for fragility fractures. Although osteoporosis is considered common in multiple sclerosis (MS), few previous studies focused on fractures in MS.
Objective: Using the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, we investigated the frequency of osteoporosis, fractures, and clinical risk factors for fracture in MS.
Methods: In 2007, 9,346 NARCOMS participants reported fractures and clinical risk factors for fractures including history of osteoporosis or osteopenia (low bone mass), sedentary level of physical activity, falls in the last year, current smoking status, family history of osteoporosis, and impaired mobility.
Results: Among responders, 2,501 (27.2%) reported low bone mass. More than 15% of responders reported a history of fracture after age 13 years (n = 1,482). Among those reporting fractures, 685 (46.2%) reported multiple fractures, while 522 (35.2%) reported a wrist fracture, 165 (11.1%) reported a vertebral fracture, and 100 (7.4%) reported a hip fracture. Excluding age, 1,413 (15.1%) participants had 1 clinical risk factor for fracture, 2,341 (25.0%) had 2, and 5,393 (57.7%) had 3 or more. Among participants with a history of fracture, 746 (55%) reported taking calcium supplements, 858 (68.8%) reported taking vitamin D supplements or a multivitamin with vitamin D, and 334 (22.5%) reported taking a bisphosphonate.
Conclusion: Patients with multiple sclerosis (MS) often have multiple risk factors for osteoporotic fractures. Many patients with MS with low bone mass or previous fractures are not taking supplemental calcium or vitamin D, suggesting a potential area of improvement in care.
Comment in
-
A cross-sectional study of bone health in multiple sclerosis.Neurology. 2010 May 11;74(19):1554; author reply 1555. doi: 10.1212/WNL.0b013e3181d8a66a. Neurology. 2010. PMID: 20458077 No abstract available.
Similar articles
-
Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.Drugs Aging. 2013 Dec;30(12):1029-38. doi: 10.1007/s40266-013-0121-9. Drugs Aging. 2013. PMID: 24114665 Clinical Trial.
-
Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland.Int J Circumpolar Health. 2013;72:19596. doi: 10.3402/ijch.v72i0.19596. Epub 2013 Jan 11. Int J Circumpolar Health. 2013. PMID: 23326764 Free PMC article.
-
Osteoporotic fractures: background and prevention strategies.Maturitas. 1996 Mar;23(2):193-207. doi: 10.1016/0378-5122(95)00974-4. Maturitas. 1996. PMID: 8735357 Review.
-
Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.Acta Orthop Traumatol Turc. 2013;47(5):318-22. doi: 10.3944/aott.2013.3065. Acta Orthop Traumatol Turc. 2013. PMID: 24164940
-
Bone loss and fracture in people with multiple sclerosis: A systematic review and meta-analysis.Mult Scler Relat Disord. 2024 Oct;90:105773. doi: 10.1016/j.msard.2024.105773. Epub 2024 Jul 15. Mult Scler Relat Disord. 2024. PMID: 39068819
Cited by
-
Impact of the Autonomic Nervous System on the Skeleton.Physiol Rev. 2018 Jul 1;98(3):1083-1112. doi: 10.1152/physrev.00014.2017. Physiol Rev. 2018. PMID: 29717928 Free PMC article. Review.
-
The risk of fracture in patients with multiple sclerosis: the UK general practice research database.J Bone Miner Res. 2011 Sep;26(9):2271-9. doi: 10.1002/jbmr.418. J Bone Miner Res. 2011. PMID: 21557309 Free PMC article.
-
Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients.Degener Neurol Neuromuscul Dis. 2019 Jun 13;9:39-53. doi: 10.2147/DNND.S204555. eCollection 2019. Degener Neurol Neuromuscul Dis. 2019. PMID: 31354380 Free PMC article.
-
Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients.Surg Neurol Int. 2019 Oct 11;10:200. doi: 10.25259/SNI_252_2019. eCollection 2019. Surg Neurol Int. 2019. PMID: 31768280 Free PMC article.
-
Pleiotropic Genetic Effects between Multiple Sclerosis and Musculoskeletal Traits.medRxiv [Preprint]. 2023 Sep 13:2023.09.12.23295444. doi: 10.1101/2023.09.12.23295444. medRxiv. 2023. PMID: 37745316 Free PMC article. Preprint.
References
-
- US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004.
-
- Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Disparities in the management of multiple sclerosis-related bladder symptoms. Neurology 2007;68:1971–1978. - PubMed
-
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: US Department of Health and Human Services; 1995.
-
- Greendale GA, Bodin-Dunn L, Ingles S, Haile R, Barrett-Connor E. Leisure, home, and occupational physical activity and cardiovascular risk factors in postmenopausal women: The Postmenopausal Estrogens/Progestins Intervention (PEPI) Study. Arch Intern Med 1996;156:418–424. - PubMed
-
- Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999;5:349–354. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical